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Intractable  fever  in  cancer  patients  is  problematic  and  the  causes  of  this  fever  can  be  diverse.  Paroxysmal  persistent 
hyperthermia  after  sudden  mental  change  or  neurologic  deficit  can  develop  via  autonomic  dysregulation  without 
infection  or  any  other  causes  of  fever.  Paroxysmal  hyperthermic  autonomic  dysregulation  is  a  rare  disease  entity.  It 
manifests  as  a  form  of  paroxysmal  hypertension,  fever,  tachycardia,  tachypnea,  pupillary  dilation,  agitation  and  extensor 
posturing  after  traumatic  brain  injury,  hydrocephalus,  brain  hemorrhage  or  brain  neoplasm.  We  recently  experienced  a 
case  of  paroxysmal  hyperthermia  following  intracerebral  hemorrhage  along  with  brain  neoplasm.  Extensive  fever 
workups  failed  to  show  an  infectious  or  inflammatory  source  and/or  hormonal  abnormality.  Empirical  treatments  with 
antibiotics,  antipyretics,  morphine,  steroid  and  antiepileptic  agents  were  also  ineffective.  However,  Propranolol,  a 
lipophilic  beta-blocker,  successfully  controlled  the  fever  and  stabilized  the  patient.  Fever  in  cancer  patients  is  a 
common  phenomenon,  but  a  central  origin  should  be  considered  when  the  fever  is  intractable.  Propranolol  is  one  of 
the  most  effective  drugs  for  treating  paroxysmal  hyperthermia  that  is  due  to  autonomic  dysregulation.
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INTRODUCTION
Fever  is  one  of  the  most  frequently  encountered  problems 
during  the  management  of  cancer  patients.  The  causes  are 
usually  infection,  other  inflammatory  sources  and/or  hormonal 
imbalances  such  as  thyroid  storm  and  pheochromocytoma. 
Extensive  workups  for  finding  the  origin  of  fever  sometimes  fail  to 
reveal  the  problem  and  empirical  treatment  with  antibiotics, 
antipyretics  or  steroid  are  tried  for  treating  the  undetermined 
infection  or  cancer  fever. 
If  the  paroxysmal  hyperthermia  is  combined  with  acute 
mental  change  or  neurologic  deficit  after  brain  injury,  central 
fever  should  be  considered.  Studies  on  central  fever  have 
sometimes  revealed  infection  of  the  central  nervous  system  or 
septic  cerebral  embolism.  According  to  some  reports, 
paroxysmal  hyperthermia  after  acute  mental  deterioration  is  due 
to  traumatic  brain  injury  and  this  is  known  as  'diencephalic 
syndrome'  or  'paroxysmal  hyperthermic  autonomic  dysregulation'; 
it  presents  with  fever,  tachycardia,  hypertension  and  seizure. 
Hyperthemia  that's  caused  by  autonomic  dysregulation  has 
usually  been  reported  in  cases  after  surgical  or  traumatic 
cerebral  hemorrhage  or  hypothalamic  damage.  However,  to  the 
best  of  our  knowledge,  there  have  been  no  reports  on 
paroxysmal  hyperthermic  autonomic  dysregulation  associated 
with  brain  tumor.  We  report  here  on  a  rare  case  of  brain  tumor 
that  presented  with  intractable  fever  and  this  was  successfully 
controlled  by  administering  propranolol.
CASE REPORT
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Figure  1.  The  brain  CT  shows  the  acute  hemorrhage  in  the  right 
basal  ganglia.
Figure  2.  The  brain  MRI  shows  residual  hematoma  in  the  right 
basal ganglia and an additional mass lesion in the splenium portion 
of  the  right  corpus  callosum.
his  acute  altered  mental  status  and  left  hemiparesis.  He  had  a 
10  year  history  of  hypertension  and  he  was  taking 
antihypertensive  drugs.  There  was  a  history  8  years  ago  of 
hypertensive  cerebral  hemorrhage,  but  no  sequelae  remained 
after  conservative  treatment.  The  family  history  and  social 
history  were  nonspecific.  On  admission,  the  body  temperature  of 
the  patient  was  36.6℃,  the  blood  pressure  was  well  controlled 
at  120/80  mmHg,  the  pulse  rate  was  60  beats  per  minute  and 
the  respiratory  rate  was  20  times  per  minute.  The  patient 
appeared  to  be  acutely  ill,  and  he  presented  with  a  comatous 
mental  status  (Glasgow  Coma  Scale  4).  His  corneal  reflex  was 
intact,  but  the  pupil  was  anisocoric.  The  motor  strength  of  the 
left  upper  and  lower  extremities  was  decreased  and  an 
abnormal  deep  tendon  reflex  was  present,  but  Babinski's  sign 
was  not  detected.  The  brain  computed  tomography  (CT) 
showed  acute  hemorrhage  in  the  right  basal  ganglia  and  the 
right  lateral  ventricle  was  displaced  because  of  a  mass  effect 
(Figure  1).  Trephination  was  performed  to  remove  the 
hematoma  and  to  decompress  the  brain.  After  trephination,  the 
Glasgow  Coma  Scale  was  improved  to  6  from  4  on  admission. 
Follow-up  brain  MRI  revealed  residual  hematoma  in  the  right 
basal  ganglia  and  an  additional  mass  lesion  in  the  splenium 
portion  of  the  right  corpus  callosum  (Figure  2).  The  tumor 
seemed  to  be  a  malignant  lesion  such  as  gliomatosis  cerebri. 
The  diagnosis  of  glioblastoma  multiforme  was  finally  confirmed 
by  stererotactic  biopsy.
The  laboratory  investigations  revealed  a  normal  peripheral 
blood  cell  count  with  a  leukocyte  count  of  6,050/mm
3,  a 
hemoglobin  level  of  14.0  g/dL  and  a  platelet  count  of 
145.000/mm
3.  The  blood  chemistry  findings,  including  the  liver 
function  tests  and  electrolytes,  were  also  within  the  normal 
ranges. 
There  was  no  fever  at  the  time  of  admission,  but  paroxysmal 
fever  developed  at  the  recovery  phase  after  stereotactic  brain 
biopsy.  Extensive  fever  workups  were  done.  The  repeated  blood 
and  cerebral  spinal  fluid  cultures  were  all  negative  for  bacterial 
growth.  The  chest  X-ray  was  normal  and  the  urinalysis  was 
also  normal.  Follow  up  brain  CT  could  not  detect  any 
inflammatory  focus,  including  abscess  formation.  Several  viral 
studies,  including  antibody  tests  for  HIV,  hepatitis  A,  B  and  C, 
cytomegalovirus  and  EB  virus,  were  all  negative.  On  the 
electroencephalogram,  there  was  no  epileptic  discharge  or 
spike-and-wave  complex.
We  could  not  find  any  source  of  infection  even  though  the 
patient  exhibited  persistent  paroxysmal  fever,  so  we  presumed 
this  was  a  cancer  fever  at  first.  We  started  high  dose  steroid 
therapy  to  control  the  cancer  fever  and  empirical  antibiotic 
treatment  was  administered  to  cover  any  undetected  bacterial 
infection.  Alas,  all  the  presumptive  treatments  were  in  vain.  We 
finally  thought  that  the  central  fever  was  due  to  autonomic 
dysregulation,  and  the  combined  clinical  patterns  such  as 
paroxysmal  hyperthermia  and  the  abrupt  blood  pressure 
elevation  were  relevant  to  the  central  origin.  The  first  choice  of 
drug  was  morphine,  but  it  was  useless.  The  next  drug  was 
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Figure  3.  The  graph  represents  the  daily  body  temperatures  and  systolic  blood  pressures  after  initiation, 
withdrawal  and  reinitiation  of  administering  propranolol.  The  upward  pointing  green  arrow  reflects  the  point  of 
time  for  dexamethasone  and  morphine  administration.  The  upward  pointing  black  arrows  reflect  the  point  of 
time for administration and readministration of propranolol. The downward pointing black arrow reflects the point 
of  time  for  withdrawal  of  propranolol.
pass  the  blood-brain-barrier.  Propranolol  successfully  controlled 
the  paroxysmal  hyperthermia  (Figure  3).  After  one  week  of 
propranolol  treatment,  we  tried  tapering  the  propranolol,  but  the 
fever  developed  again.  Therefore,  we  continuously  maintained 
the  dose  of  the  drug.
Even  though  the  fever  and  blood  pressure  were  stably 
controlled  thereafter,  his  mental  status  didn't  improve.  Sadly,  the 
patient  succumbed  to  aspiration  pneumonia  one  month  later. 
DISCUSSION
Paroxysmal  hyperthermic  autonomic  dysregulation  is  a 
syndrome  that  occurs  spontaneously  and  it  arrives  from  an 
unknown  cause.  It  is  commonly  associated  with  closed  head 
injury  and  hydrocephalus.  Typically,  there  are  nonsustained 
episodes  of  hyperpyrexia,  tachycardia,  tachypnea,  increased 
blood  pressure,  increased  extensor  tone,  pupil  dilation  and 
diaphoresis
1-4).  The  theories  regarding  the  cause  of  this 
syndrome  include  several  neuroimmunologic  mechanisms.  One 
theory  is  the  initial  release  of  several  cytokines  (IL-1,  IL-6, 
TNF-α  and  IFN-γ)  that  is  secondary  to  the  direct  trauma, 
infection  of  the  brain,  the  inflammatory  stimulation  and  the 
increased  intracranial  pressure  after  acute  brain  injury  via  the 
activate  cyclooxygenase-2  pathways  in  the  periventricular  cells 
and  the  production  of  prostaglandin  E2
5,  6).  Another  theory  is  the 
stressed  cells  after  brain  injury  synthesize  heat  shock  proteins  in 
a  coordinated  response  to  tissue  injury.  Hilaire  et  al.  have 
described  that  this  hyperthermia  is  associated  with  glutamate 
and  nitric  oxide  release,  which  is  caused  by  autonomic 
dysregulation  of  the  brain  stem
7-9). 
Because  this  syndrome  is  diagnosed  from  clinical 
impressions,  the  differential  diagnosis  from  infection,  epileptic 
disorders,  pheochromocytoma,  neuroleptic  malignant  syndrome, 
increased  intracranial  pressure,  hydrocephalus,  Cushing's 
syndrome,  thyrotoxicosis  and  deep  vein  thrombosis  is  essential 
and  multidisciplinary  approaches  with  other  specialists  are 
usually  necessary
1, 4, 9). 
Administering  pharmacological  agents  that  control  the 
neurotransmitters  in  the  complex  autonomic  nervous  systems 
that  are  associated  with  autonomic  regulation  can  be 
considered  for  treating  hyperthermia,  increased  blood  pressure, 
seizure  and  the  secondary  complications
10-14).  The  current 
effective  drugs  are  propranolol  (β-blockers),  opioid,  clonidine 
(α2-agonist),  bromocriptine  (dopamine  agonists),  chlorpromazine 
(phenothiazine),  dantrolene  (muscle  relaxants)  and  etc
15-18). 
Stereotactic  surgery  is  sometimes  considered  when  these  drugs 
are  ineffective
19).
This  present  case  demonstrates  that  uncontrolled  fever  in  the 
patients  suffering  with  brain  injury  by  any  causes  should  be 
viewed  as  possible  paroxysmal  hyperthermic  autonomic  dysregula-
tion.  Pharmacologic  treatment  that  can  control  the  hypothalamic 
thermoregulatory  dysfunction  should  be  considered.
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